Vertical: CNMBase Year: 2025
Market Size (2025)
$408.75M
Projected (2032)
$564.65M
CAGR (2022–2032)
4.7%
Key Players
9+
Market Overview
The Global Feed Vitamins Market was valued at USD 408.75 million in 2025 and is projected to reach USD 564.65 million by 2032, registering a CAGR of 4.72% over 2026–2032. The market has expanded steadily from USD 355.79 million in 2022, and the forecast implies an absolute increase of USD 155.90 million between 2025 and 2032. Growth is underpinned by rising global consumption of poultry meat, pork, eggs and dairy products, the continued shift from backyard to commercial livestock production, and the need for compound feed manufacturers to guarantee consistent micronutrient levels in diets formulated for high-performing animal genetics.
Feed vitamins are a small cost component of a finished ration, but they are essential to growth, fertility, immune response, skeletal integrity and the quality of meat, eggs and milk. Demand is therefore tied closely to the volume of industrial compound feed and to the inclusion rates recommended by nutritionists, rather than to short-term changes in livestock profitability. At the same time, the market is shaped by an unusually concentrated supply base: production of vitamins A and E, in particular, depends on a small number of chemical synthesis routes operated by a limited group of manufacturers in Europe and China. This structure has produced sharp price cycles, most recently following the fire at a BASF precursor plant in Ludwigshafen, Germany, in July 2024, which led to force majeure on selected vitamin A, vitamin E and carotenoid products.
Key Findings
By vitamin type: Vitamin B Group is both the largest and the fastest-growing segment, accounting for 30.0% of the market in 2025 (USD 122.62 million) and expanding at a CAGR of 5.34% to reach USD 176.51 million in 2032. Vitamin E and Others each hold a 25.0% share (USD 102.19 million) in 2025, while Vitamin A accounts for 20.0%.
By livestock: Poultry is the largest and fastest-growing segment, representing 50.0% of 2025 revenue (USD 204.37 million) and growing at a CAGR of 5.18% to USD 291.02 million in 2032. Swine and Others each account for 25.0% of the market in 2025.
By region: Asia Pacific leads the market with USD 155.32 million in 2025 (38.0% share) and is forecast to reach USD 225.63 million by 2032 at a CAGR of 5.48%. Middle East & Africa is the fastest-growing region, with a CAGR of 6.31%, rising from USD 20.44 million in 2025 to USD 31.39 million in 2032.
By country: China is the largest individual country market, valued at USD 69.90 million in 2025 (17.1% of the global market) and projected to reach USD 98.38 million in 2032. India is the fastest-growing country, with a CAGR of 7.71%, increasing from USD 21.75 million in 2025 to USD 36.64 million in 2032.
Segmentation Summary
The market is analysed by vitamin type (Vitamin E, Vitamin A, Vitamin B Group and Others) and by livestock (Poultry, Swine and Others), across five regions and twenty country-level markets. Water-soluble B-group vitamins benefit from broad use across all species and from rising inclusion in poultry diets, while the fat-soluble vitamins A and E remain core components of every premix but grow more slowly, partly because their price volatility encourages nutritionists to optimise inclusion levels. Poultry dominates demand in every region except Germany and Spain, where swine production accounts for the largest share of feed vitamin consumption.
Competitive Landscape Summary
The supply side is moderately consolidated. A small number of integrated producers, including dsm-firmenich (Animal Nutrition & Health), BASF, Zhejiang NHU, Zhejiang Medicine and Adisseo, control most of the global capacity for vitamins A and E, while Chinese specialists such as Jiangxi Tianxin Pharmaceutical, Brother Enterprises and Zhejiang Garden Bio-chemical hold strong positions in B-group vitamins, vitamin K3 and vitamin D3. Premix manufacturers such as Trouw Nutrition (Nutreco) form the main link between vitamin producers and feed mills. A major structural change is under way: in February 2026, dsm-firmenich agreed to divest its Animal Nutrition & Health business to CVC Capital Partners, with completion expected at the end of 2026.
Challenges and Opportunities
Challenges: Supply concentration and the dependence of vitamins A and E on a few precursor chains expose buyers to severe price spikes; energy costs in Europe have previously forced production cuts; and outbreaks of African swine fever and highly pathogenic avian influenza can disrupt livestock populations and feed demand at short notice.
Opportunities: Rapid expansion of commercial poultry production in India, Southeast Asia, the Middle East and Africa; growing interest in precision and optimum vitamin nutrition as a tool to support animal health in production systems with reduced antibiotic use; and the development of higher-stability formulations and metabolites such as 25-hydroxy vitamin D3.
Future Outlook
Over 2026–2032, the market is expected to add USD 155.90 million in value. Asia Pacific alone is projected to contribute USD 70.31 million of this increase, reflecting its large and growing livestock base. Mature markets in North America and Europe will grow more slowly, at CAGRs of 3.74% and 3.48% respectively, with growth driven by feed-efficiency and animal-welfare requirements rather than by herd expansion. Competitive dynamics will be shaped by the reorganisation of dsm-firmenich's animal nutrition business, continued capacity investment by Chinese producers, and buyers' efforts to diversify supply sources following the 2024 disruption.
The Feed Vitamins Market market is projected to grow at a CAGR of 4.7% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Feed vitamins are organic micronutrients added to compound feed, premixes, concentrates and mineral supplements to meet the physiological requirements of livestock that cannot be met reliably through feed raw materials alone. They are classified into fat-soluble vitamins (A, D, E and K) and water-soluble vitamins (the B-group vitamins, comprising thiamine (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), pyridoxine (B6), biotin (B7), folic acid (B9) and cobalamin (B12), together with vitamin C). Commercial feed vitamins are supplied mostly in stabilised, feed-grade forms such as spray-dried or beadlet powders, adsorbates and coated products, which protect the active substance from oxidation, heat and moisture during feed processing and storage.
In the European Union, vitamins used in animal nutrition are authorised as nutritional additives under Regulation (EC) No 1831/2003, within the functional group "vitamins, pro-vitamins and chemically well-defined substances having similar effect". Comparable feed additive or feed ingredient frameworks apply in the United States, China, Brazil, Canada and India.
Included: feed-grade vitamins E, A and B-group vitamins, and other feed vitamins (including vitamin D3, vitamin K3 and vitamin C) sold for use in feed for poultry, swine and other livestock, whether supplied as single vitamins or used by premix manufacturers.
Excluded: vitamins for human food, dietary supplements and pharmaceuticals; veterinary injectable vitamin products; carotenoids used for pigmentation; minerals, amino acids, enzymes and other non-vitamin feed additives; and the value added by premix manufacturers beyond the vitamin content.
Scope of the Study
The study covers the global market for feed vitamins, measured in USD Million. Historic data are presented for 2022–2024, 2025 is the base year, and forecasts cover 2026–2032. Compound annual growth rates refer to the period 2026–2032.
By Vitamin Type: Vitamin E, Vitamin A, Vitamin B Group, Others
By Livestock: Poultry, Swine, Others
By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, with twenty country-level markets
Research Objectives
To estimate the size of the global feed vitamins market for 2022–2025 and forecast its value for 2026–2032 in USD Million.
To analyse the market by vitamin type (Vitamin E, Vitamin A, Vitamin B Group, Others) and by livestock (Poultry, Swine, Others), identifying the largest and fastest-growing segments.
To assess regional and country-level demand across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
To evaluate the drivers, restraints, opportunities and trends affecting demand, including livestock production growth, antibiotic growth promoter restrictions and vitamin price volatility.
To examine the feed vitamin value chain, from chemical precursors and fermentation inputs to premix manufacturers, feed mills and livestock producers.
To review the regulatory frameworks governing feed vitamin authorisation, maximum inclusion levels and feed safety in major regions.
To profile the competitive landscape, including the positioning of leading producers and their strategic developments from 2022 onward.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured research process combining secondary research, primary research and analytical modelling. The process begins with defining the market scope and segmentation, followed by collection of data on livestock populations, compound feed production, vitamin inclusion rates, production capacities and prices. These data are used to construct market estimates, which are validated through consultation with industry participants and then projected over the forecast period using a factor-based forecasting model.
Step 1 – Scope definition: definition of the market, segmentation and geographical coverage.
Step 2 – Data collection: secondary research followed by primary interviews with supply-side and demand-side participants.
Step 3 – Market estimation: top-down and bottom-up sizing, reconciled through data triangulation.
Step 4 – Forecasting: projection of segment and regional values over 2026–2032 using demand drivers and constraints.
Step 5 – Validation: review of estimates against industry feedback and internal consistency checks.
Secondary Research
Secondary research was used to build an understanding of market structure, production capacity, demand patterns and regulation. The principal source types for this industry include:
Industry associations: feed industry and animal nutrition associations such as the International Feed Industry Federation (IFIF), FEFAC (European Feed Manufacturers' Federation), FEFANA (EU Association of Specialty Feed Ingredients and their Mixtures), the American Feed Industry Association (AFIA) and the China Feed Industry Association.
Government and regulatory bodies: the European Food Safety Authority (EFSA) and the EU Register of Feed Additives, the US Food and Drug Administration Center for Veterinary Medicine, the US Department of Agriculture, China's Ministry of Agriculture and Rural Affairs, Brazil's Ministry of Agriculture and Livestock (MAPA), the Canadian Food Inspection Agency and the Bureau of Indian Standards.
Intergovernmental organisations: the Food and Agriculture Organization (FAO) and the OECD-FAO Agricultural Outlook for livestock production and meat consumption data.
Company filings: annual reports, investor presentations and stock exchange disclosures of vitamin producers and animal nutrition companies.
Trade journals and industry media: publications covering feed, animal nutrition and fine chemicals, including price reporting for vitamins A, E, D3 and B-group vitamins.
Paid databases: trade statistics, company databases and commodity price databases.
Primary Research
Primary research was conducted to validate secondary findings, fill information gaps and obtain qualitative insights into market dynamics. Interviews were carried out through telephone, video and email exchanges.
Supply-side respondents included executives and product managers at vitamin manufacturers, premix producers, distributors and traders, covering production capacity, pricing, product portfolios and regional sales.
Demand-side respondents included nutritionists and procurement managers at compound feed mills, integrated poultry and swine producers, and dairy and aquaculture operations, covering vitamin inclusion practices, purchasing behaviour, supplier selection and expected changes in demand.
The objectives of primary research were to verify market size estimates and segment splits, understand the impact of recent supply disruptions on purchasing patterns, assess growth expectations by region and livestock type, and validate key trends and competitive positioning.
Market Size Estimation
Top-down approach: the total feed vitamin market was estimated from global and regional compound feed production and the share of vitamins in feed additive expenditure, and then allocated to vitamin types, livestock categories and regions using consumption patterns, inclusion rates and regional production data.
Bottom-up approach: country-level demand was built up from livestock populations and feed volumes by species, multiplied by typical vitamin inclusion rates and average realised prices for each vitamin type. Country estimates were aggregated to regional and global totals.
Data triangulation: the results of the two approaches were compared and reconciled with supply-side information, including producer revenues and capacity data, and with feedback from primary interviews. Differences were investigated and resolved to produce a single consistent set of estimates across all segmentations.
Forecasting Methodology
Forecasts for 2026–2032 were developed for each country, vitamin type and livestock category, and then aggregated. Factors considered include projected growth in meat, egg and milk production, expansion of commercial and integrated livestock operations, compound feed penetration, changes in recommended inclusion rates, regulatory developments such as restrictions on antibiotic growth promoters and maximum vitamin levels, expected price trends for individual vitamins, and new production capacity. Each factor was weighted according to its expected impact over the short, medium and long term, and the resulting forecasts were checked for consistency with historic trends and industry expectations.
Base Year, Forecast Period and Currency
Historic years: 2022, 2023, 2024
Base year: 2025
Forecast period: 2026–2032
CAGR period: 2026–2032
Currency: USD Million
Assumptions and Limitations
Market values are expressed in current US dollars; exchange-rate movements over the forecast period are not modelled separately.
Vitamin prices are assumed to follow normalised trends over the forecast period, without a recurrence of the extreme supply disruptions seen in 2022 and 2024.
Regulatory frameworks governing feed additives in the major regions are assumed to remain broadly stable, with no outright prohibition of any major feed vitamin.
Livestock production is assumed to grow in line with long-term consumption trends, without major long-lasting losses from disease outbreaks.
Market values reflect the value of vitamins sold for feed use and exclude the margin added by premix and compound feed manufacturers.
Data for smaller markets grouped under "Rest of" categories are estimated with less granular inputs than those for the individually covered countries.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global feed vitamins market is moderately consolidated at the production level. Manufacturing of the major fat-soluble vitamins, especially vitamins A and E, is concentrated among a small number of integrated producers in Europe and China that control key precursor chains, while B-group vitamins, vitamin D3 and vitamin K3 are produced largely by Chinese specialists. China accounts for the large majority of global vitamin output. At the distribution level, the market is more fragmented, with numerous premix manufacturers, distributors and traders serving feed mills and integrators in each region.
Competition is based on production cost, reliability of supply, product quality and stability, breadth of portfolio, and technical service. Price competition is intense for commodity vitamins, and market conditions alternate between periods of oversupply and shortages caused by plant outages. Leading producers are pursuing backward integration into intermediates, capacity expansion, product differentiation through improved formulations and metabolites, and portfolio restructuring. The most significant structural change during the period is dsm-firmenich's agreement to divest its Animal Nutrition & Health business to CVC Capital Partners.
Key Player Positioning
Leading companies in the market are classified below as market leaders, challengers and niche or specialist players, based on their product portfolio, production scale, integration and geographic reach.
Market leaders dsm-firmenich (Animal Nutrition & Health): One of the longest-established and broadest feed vitamin suppliers, offering vitamins A, D3, E, K3, the B group and C under the ROVIMIX brand, together with premixes and precision services. The Animal Nutrition & Health business reported net sales of about EUR 3.5 billion in FY2025. In February 2026, dsm-firmenich agreed to divest the business to CVC Capital Partners at an enterprise value of about EUR 2.2 billion, with completion expected at the end of 2026; it will retain a 20% stake in the vitamins-focused Essential Products company.
BASF SE: A major integrated producer of vitamins A and E and their precursors at Ludwigshafen, Germany, also supplying vitamins B2 and B5 to the feed industry under the Lutavit brand. BASF reported group sales of EUR 59.7 billion in FY2025, with its Nutrition & Health division generating EUR 1,744 million. Production affected by the July 2024 fire largely normalised during 2025, and the company is investing to increase vitamin E acetate capacity.
Zhejiang NHU Co., Ltd.: One of the world's largest producers of vitamins A and E, with a portfolio that also includes vitamin D3, vitamin B12 and biotin, as well as methionine. NHU reported operating revenue of RMB 22.25 billion in FY2025. Its strategy centres on backward integration from citral and on biomanufacturing.
Zhejiang Medicine Co., Ltd.: A leading Chinese producer of synthetic vitamins E and A, biotin and vitamin D3, with a significant pharmaceutical business. The company reported revenue of RMB 8.88 billion in FY2025 and is investing in in-house production of vitamin intermediates.
Adisseo (Bluestar Adisseo Co.): A global animal nutrition company with a long-standing vitamin franchise under the Microvit brand, covering vitamins A, D3, E, K3, the B group and C, alongside its leading methionine business. Adisseo reported operating revenue of about RMB 17.23 billion in FY2025.
Challengers
Jiangxi Tianxin Pharmaceutical Co., Ltd.: A B-vitamin specialist with leading positions in vitamins B1 and B6, expanding into vitamins B5, A and D3 and 25-hydroxy vitamin D3. The company reported revenue of RMB 2,345 million in FY2025, with vitamins accounting for most of its main business revenue.
Brother Enterprises Holding Co., Ltd.: A producer of vitamins K3, B1, B3 and B5, with cost advantages from its integrated chromium chemistry and operations in South Africa through Brother CISA. The company reported revenue of RMB 3,611.8 million in FY2025.
Niche and specialist players
Zhejiang Garden Bio-chemical High-tech Co., Ltd.: A specialist in vitamin D3 and 25-hydroxy vitamin D3, integrated from lanolin-derived cholesterol, and also producing vitamin A. The company reported revenue of approximately RMB 1.24 billion in FY2025 and is diversifying into vitamins A and E powders, B6 and biotin.
Trouw Nutrition (Nutreco): A global premix and feed specialty company owned by SHV Holdings, which purchases vitamins and supplies vitamin-mineral premixes to feed mills and integrators. Nutreco operates 94 production plants in 32 countries; its revenue is not separately disclosed by SHV.
Competitor Dashboard
The competitor dashboard rates each profiled company on four parameters: breadth of feed vitamin product portfolio, regional presence, strategic alliances and industry experience. Ratings are qualitative assessments on a four-point scale of Low, Medium, High and Very High.
Porter's Five Forces analysis assesses the competitive intensity and attractiveness of the feed vitamins market from the perspective of vitamin producers.
Threat of new entrants: Low
Production of most feed vitamins requires complex chemistry or fermentation know-how, large-scale plants and access to key intermediates, creating high capital and technology barriers.
New products must obtain feed additive authorisation in each major market, which involves dossier preparation and safety assessments.
Established producers benefit from economies of scale and long-standing relationships with premix manufacturers.
Bargaining power of suppliers: Medium
Key intermediates such as citral and isophytol are produced by a limited number of companies, and many leading producers are integrated into these intermediates.
Non-integrated producers depend on external supply of intermediates and energy, exposing them to cost increases, as seen during the European energy crisis of 2022.
Bargaining power of buyers: Medium
Large premix manufacturers and integrators buy significant volumes and can switch between suppliers for commodity vitamins.
Buyer leverage is limited during supply shortages, when allocation and force majeure measures shift power to producers.
Vitamins are essential and represent a small share of total feed cost, which limits price sensitivity at the level of the finished feed.
Threat of substitutes: Low
There are no practical substitutes for vitamins as essential nutrients; natural feed ingredients contain variable and often insufficient levels.
Alternative forms, such as natural vitamin E or vitamin D3 metabolites, are substitutes within the vitamin category rather than outside it.
Intensity of competitive rivalry: High
Competition between Chinese and Western producers is intense, especially in commodity vitamins where price is the main purchasing criterion.
Capacity additions in China have led to periods of oversupply and low prices, alternating with shortages following plant outages.
Producers compete on cost, reliability of supply, product quality and technical service.
Threat of new entrants: Low; Production of most feed vitamins requires complex chemistry or fermentation know-how, large-scale plants and access to key intermediates, creating high capital and technology barriers.
Bargaining power of suppliers: Medium; Key intermediates such as citral and isophytol are produced by a limited number of companies, and many leading producers are integrated into these intermediates.
Bargaining power of buyers: Medium; Large premix manufacturers and integrators buy significant volumes and can switch between suppliers for commodity vitamins.
Threat of substitutes: Low; There are no practical substitutes for vitamins as essential nutrients; natural feed ingredients contain variable and often insufficient levels.
Intensity of competitive rivalry: High; Competition between Chinese and Western producers is intense, especially in commodity vitamins where price is the main purchasing criterion.
Market estimates by geography (2032)
InsightAsia Pacific leads with $225.63M by 2032, while Middle East & Africa is projected to grow fastest at a 6.4% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $80.41M | $96.84M | $116.32M | 3.8% | 21% |
| Europe | $80.94M | $96.39M | $114.34M | 3.5% | 20% |
| Asia Pacific | $132.21M | $172.87M | $225.63M | 5.5% | 40% |
| Latin America | $45.29M | $59.09M | $76.96M | 5.4% | 14% |
| Middle East & Africa | $16.94M | $23.13M | $31.39M | 6.4% | 6% |
| Total | $355.79M | $448.32M | $564.65M | 4.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$564.65M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Vitamin B Group | $176.51M | 5.4% | 31% |
| Others | $145.11M | 5.1% | 26% |
| Vitamin E | $136.42M | 4.2% | 24% |
| Vitamin A | $106.61M | 3.9% | 19% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Feed Vitamins Market covering market dynamics, competitive landscape, and strategic outlook.
The Feed Vitamins Market market is projected to reach $564.65M by 2032, growing at 4.7% CAGR. The Vitamin B Group segment holds the largest share.
The feed vitamins market is driven primarily by the scale and structure of global livestock production. Demand grows with compound feed output and with the intensification of poultry and swine farming, while supply-side factors, notably the concentration of production and the volatility of vitamin prices, influence purchasing behaviour and inclusion rates. This chapter examines the factors that promote and inhibit growth over the forecast period.
Market Growth Factor Analysis
The table below summarises five macro-level and five micro-level factors influencing the market. Each factor is classified by its impact type (promoting, inhibiting or steady) and assigned an impact score out of 10 for three periods: 2026–2027, 2028–2030 and 2031–2032. A higher score indicates a stronger influence on the market. The scores are analyst assessments based on the secondary and primary research conducted for this study.
Rising global demand for animal protein
Growth in the consumption of poultry meat, pork, eggs and dairy products is the most important driver of feed vitamin demand. According to the OECD-FAO Agricultural Outlook 2026–2035, global meat consumption is projected to reach about 412 million tonnes by 2035, an increase of around 12% over the outlook period, with poultry meat accounting for the largest share of the additional volume. This growth is concentrated in developing economies in Asia, Africa and Latin America, where rising incomes and urbanisation are shifting diets towards animal-source foods.
Each additional tonne of meat or eggs requires a corresponding volume of balanced feed fortified with vitamins. Because vitamins are essential for growth, bone development, immunity and reproductive performance, their inclusion is not discretionary in commercial production. The market data reflect this link: Poultry is the largest livestock segment in 2025 at USD 204.37 million and is projected to reach USD 291.02 million in 2032, while Asia Pacific, the largest consumer of animal protein, is forecast to add USD 70.31 million in market value between 2025 and 2032.
Industrialisation of livestock production and growth of compound feed
The shift from backyard and smallholder systems to commercial, integrated livestock operations is increasing the use of manufactured compound feed and premixes, which carry standardised vitamin fortification. Modern broiler, layer and swine genetics have high growth rates and productivity, and their nutrient requirements are met through precisely formulated diets rather than forage or by-products. This structural change is most pronounced in China, India, Southeast Asia, Brazil and the Middle East.
Integrated producers and large feed mills purchase vitamins through premix suppliers and follow inclusion recommendations published by vitamin producers and research institutions. As the share of animals reared on commercial feed rises, so does the volume of vitamins consumed per unit of livestock output. This trend supports the higher growth rates forecast for emerging markets: India is expected to grow at a CAGR of 7.71%, Saudi Arabia at 7.14% and Mexico at 5.79% over 2026–2032, well above the global average of 4.72%.
Restrictions on antibiotic growth promoters and focus on animal health
Regulators in major producing countries have restricted the use of antibiotics as growth promoters in feed. The European Union banned antibiotic growth promoters in 2006, and China's Ministry of Agriculture and Rural Affairs, through Announcement No. 194 of 2019, ended the production and import of growth-promoting feed additives from 1 January 2020 and their use in commercial feed from 1 July 2020. In the United States, the medically important antimicrobials used in feed have been placed under veterinary oversight.
Without antibiotic growth promoters, producers rely more heavily on nutrition to maintain animal health, gut integrity and immune function. Vitamins E, A, D3 and C, together with several B-group vitamins, play recognised roles in immune response and antioxidant protection, and many nutritionists have adopted vitamin supplementation levels above minimum requirements as part of broader health management strategies. This trend supports both volume growth and the adoption of higher-value forms such as 25-hydroxy vitamin D3.
Focus on productivity, feed efficiency and product quality
Feed accounts for the largest share of livestock production costs, and producers continually seek to improve feed conversion, growth rates and reproductive performance. Adequate vitamin supply is a low-cost lever for these outcomes: deficiencies or marginal shortfalls can cause leg disorders in broilers, poor eggshell quality in layers, reduced litter size in sows and impaired fertility in cattle. As genetic potential rises, the margin for error in micronutrient supply narrows.
In addition, retailers and consumers increasingly value product quality attributes that are influenced by vitamin nutrition, such as the oxidative stability and shelf life of meat (supported by vitamin E) and egg quality. These requirements encourage feed formulators to maintain robust vitamin levels even during periods of high prices, which helps to sustain demand for core vitamins such as Vitamin E, which is projected to grow from USD 102.19 million in 2025 to USD 136.42 million in 2032.
Expansion of commercial poultry production in emerging markets
Commercial poultry production is growing rapidly in India, Southeast Asia, the Middle East and Africa, supported by population growth, urbanisation and the relatively low cost of poultry meat and eggs. Poultry accounts for 66.7% of the India market and 67.8% of the Middle East & Africa market in 2025, and both markets are forecast to grow faster than the global average. Vitamin producers and premix companies that establish local distribution, technical service and premix capacity in these regions are well placed to capture this growth.
Higher-value and differentiated vitamin forms
There is growing demand for vitamin products that offer improved stability, bioavailability or functionality, such as coated and cross-linked beadlet forms for pelleted and extruded feed, and metabolites such as 25-hydroxy vitamin D3, which is used to support bone development and eggshell quality. Several producers have invested in these products, including Jiangxi Tianxin Pharmaceutical's 25-hydroxy vitamin D3 project and BASF's Lutavit A/D3 1000/200 NXT launch in 2025. Such products allow suppliers to differentiate beyond price.
Supply diversification and regional production
The disruptions of 2022 and 2024 highlighted the risks of concentrated supply, and feed manufacturers and integrators are seeking to diversify their supplier base. This creates opportunities for producers adding new capacity, for companies investing in backward integration into intermediates, and for fermentation-based production routes for certain vitamins. For example, Zhejiang Medicine approved a project in 2025 to produce its own vitamin intermediates, and BASF announced an investment to increase vitamin E acetate capacity by 10% by 2027.
Price volatility and supply concentration
The production of feed vitamins, particularly vitamins A and E, is concentrated among a few manufacturers using complex multi-step chemical syntheses that share key intermediates such as citral and isophytol. Disruption at a single plant can therefore tighten global supply. In November 2022, DSM temporarily halted production of animal-grade vitamin A in Europe because of high energy costs. In July 2024, a fire at a BASF plant in Ludwigshafen producing vitamin A and E precursors led BASF to declare force majeure on selected vitamin A, vitamin E and carotenoid products, and prices for vitamins A and E in China rose sharply within weeks. Such volatility complicates budgeting for feed mills and encourages nutritionists to reduce inclusion rates to minimum levels during price spikes, dampening demand in value terms over subsequent periods.
Feed cost pressure and livestock disease outbreaks
When grain and protein meal prices rise, or when livestock prices fall, producers seek to reduce feed costs, and micronutrient specifications can come under review. Outbreaks of African swine fever, which has significantly reduced pig herds in China and other Asian countries since 2018, and recurring outbreaks of highly pathogenic avian influenza in poultry flocks across Europe, North America and Asia, can cause sudden falls in animal numbers and feed demand. These factors contribute to the slower growth of the Swine segment, which is forecast to grow at a CAGR of 3.95% compared with 5.18% for Poultry.
Regulatory limits and authorisation requirements
Feed vitamins are subject to authorisation and, in some cases, maximum inclusion levels. In the European Union, all feed additives must be authorised following a safety and efficacy assessment by EFSA, and authorisations must be renewed periodically. Maximum levels apply to certain vitamins; for example, Commission Implementing Regulation (EU) 2017/1492 set maximum contents for vitamin D3 in feed for different species. These requirements raise the cost and time of bringing new products to market and limit the scope for increasing inclusion rates in mature markets.
Ownership change at the largest Western producer
In February 2026, dsm-firmenich agreed to sell its Animal Nutrition & Health business to CVC Capital Partners at an enterprise value of about EUR 2.2 billion. The business is to be separated into an Essential Products company, covering vitamins, carotenoids and aroma ingredients, and a Solutions company, covering performance solutions, premix and precision services, with completion expected at the end of 2026. The change is likely to affect commercial strategies, pricing behaviour and partnerships in the vitamin market.
Backward integration and capacity expansion in China
Chinese producers continue to invest in intermediates and new vitamin capacity. Zhejiang NHU, Zhejiang Medicine, Jiangxi Tianxin and Zhejiang Garden have each announced or commissioned projects since 2022 to expand their vitamin portfolios or secure precursor supply, reinforcing China's position as the main global production base.
Precision nutrition and data-driven formulation
Feed producers are adopting more precise formulation tools that adjust vitamin levels by species, age, production stage and environmental conditions. This approach can raise inclusion levels for high-value animals and stress periods while avoiding over-supplementation, supporting demand for advisory services from vitamin producers and premix suppliers.
Challenge: managing price cycles and quality assurance
Vitamin prices remain cyclical. Prices for vitamins A and E fell back significantly during 2025 after the 2024 spike and rose again in the first half of 2026. Buyers face the challenge of managing inventory and contracts through these cycles, while also verifying product quality and traceability across a supply chain that increasingly includes multiple sources and traders.
The feed vitamin value chain links the chemical and fermentation industries with livestock production. Value is created mainly at the manufacturing and formulation stages, where synthesis technology, stabilisation and quality control determine product performance and cost.
Raw materials and inputs
Vitamins A and E are produced by multi-step chemical synthesis from petrochemical and other intermediates, including citral, beta-ionone, isophytol and trimethylhydroquinone. Several B-group vitamins and vitamin C are produced by chemical synthesis or fermentation using glucose and other substrates, while vitamin D3 is derived from cholesterol obtained from lanolin. Vitamin K3 production is linked to chromium chemistry. Access to these intermediates is a key source of cost advantage for integrated producers.
Manufacturing and formulation
Vitamin producers synthesise the active substance and convert it into feed-grade forms such as spray-dried powders, beadlets, adsorbates and coated products that withstand pelleting, extrusion and storage. Production is capital-intensive and concentrated in Europe and China, with major sites in Switzerland, Germany, France and the Chinese provinces of Zhejiang, Jiangxi and Shandong.
Premix and distribution
Most feed vitamins are sold to premix manufacturers, which combine vitamins, trace minerals and other additives into blends tailored to species and production stage. Premixes are supplied to feed mills and integrators, either directly or through distributors and traders. Some large integrators produce their own premixes and buy vitamins directly from manufacturers.
End users
Compound feed manufacturers and integrated livestock producers in the poultry, swine, ruminant and aquaculture sectors incorporate vitamins into finished feed. Their purchasing decisions are guided by nutritionists and by the recommendations of vitamin and premix suppliers, which often provide technical services and formulation support.
Feed vitamins are regulated as feed additives or feed ingredients in all major markets. The key frameworks by region are summarised below.
European Union
Feed vitamins are authorised as nutritional additives under Regulation (EC) No 1831/2003 on additives for use in animal nutrition, following a scientific assessment by the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Authorised additives are listed in the EU Register of Feed Additives. Commission Implementing Regulation (EU) 2017/1492 sets maximum contents for vitamin D3 in complete feed by species. Feed hygiene requirements apply under Regulation (EC) No 183/2005.
United States
Feed ingredients are regulated by the Food and Drug Administration's Center for Veterinary Medicine under the Federal Food, Drug, and Cosmetic Act. Many vitamins used in animal feed are listed as generally recognised as safe under 21 CFR Part 582. Feed facilities are subject to the Food Safety Modernization Act preventive controls for animal food (21 CFR Part 507). The FDA's memorandum of understanding with the Association of American Feed Control Officials (AAFCO) on ingredient definitions expired on 1 October 2024 and was replaced by the FDA's Animal Food Ingredient Consultation process.
China
Feed additives are governed by the Regulations on the Administration of Feed and Feed Additives and by the Catalogue of Feed Additives issued by the Ministry of Agriculture and Rural Affairs (MARA), which lists the vitamins permitted for use in feed. MARA Announcement No. 194 of 2019 ended the use of growth-promoting medicated feed additives from 1 July 2020.
Canada
The Canadian Food Inspection Agency administers the Feeds Act and the Feeds Regulations, 2024, which modernised the feed regulatory framework and were phased in through 2025.
Brazil
The Ministry of Agriculture and Livestock (MAPA) regulates feed additives, including vitamins classified as nutritional additives, under Normative Instruction No. 13 of 30 November 2004.
India
The Bureau of Indian Standards sets specifications for compounded feeds, including IS 1374 for poultry feeds and IS 2052 for compounded cattle feeds, together with analytical standards for vitamins in animal feeding stuffs.
The table below summarises key developments by leading companies from 2022 onward, including capacity expansions, product launches, acquisitions, divestments and partnerships.
Nov 2022: DSM; Production adjustment; Temporarily halted production of animal-grade vitamin A in Europe and reduced output of Rovimix E-50 because of high energy costs.
Jan 2023: Zhejiang NHU; Partnership; Agreed a joint methionine project with Sinopec Zhenhai Refining & Chemical, expanding its animal nutrition portfolio.
Feb 2023: DSM; Production restart; Resumed production of animal-grade vitamin A at its Sisseln site in Switzerland.
Feb 2023: Adisseo; Acquisition; Completed the acquisition of Nor-Feed, a producer of plant extract-based feed additives.
Aug 2023: Adisseo; Expansion; Announced a 150,000 tonnes per year powder methionine plant in Quanzhou, China, scheduled to start in 2027.
Jan 2024: ADM / Trouw Nutrition; Acquisition; ADM agreed to acquire PT Trouw Nutrition Indonesia, including two premix plants.
Feb 2024: Jiangxi Tianxin Pharmaceutical; Expansion; Brought its 3,000 tonnes vitamin B5 project into use.
Jun 2024: Zhejiang NHU; Partnership; Formed a strategic biomanufacturing partnership with Bota Bio, with jointly developed fermentation strains in commercial use.
Aug 2024: BASF; Force majeure; Declared force majeure on selected vitamin A, vitamin E and carotenoid products following a fire at its Ludwigshafen precursor plant on 29 July 2024.
Oct 2024: Jiangxi Tianxin Pharmaceutical; Expansion; Brought the first 500 tonnes phase of its 1,000 tonnes vitamin A project into use.
Jan 2025: BASF; Expansion; Announced an investment to increase vitamin E acetate capacity by 10% by 2027.
Feb 2025: dsm-firmenich; Divestment; Agreed to sell its stake in the Feed Enzymes Alliance to Novonesis for EUR 1.5 billion; the transaction closed in June 2025.
Jul 2025: Zhejiang NHU; Expansion; Its 180,000 tonnes liquid methionine project with Sinopec entered trial production.
2025: BASF; Production restart; Restored vitamin A and E production at Ludwigshafen and lifted force majeure on numerous animal nutrition products.
2025: Zhejiang Garden Bio-chemical; Expansion; Its vitamin B6 and biotin projects entered trial production.
Oct 2025: Zhejiang Medicine; Expansion; Approved the Changbei Bio project, of about RMB 1.685 billion, to produce vitamin intermediates in-house, to be built in two phases through December 2027.
Oct 2025: Brother Enterprises; Investment; Completed a private placement raising RMB 436.7 million in gross proceeds.
Nov 2025: BASF; Product launch; Launched Lutavit A/D3 1000/200 NXT, a combined vitamin A and D3 product for animal nutrition, produced at Ludwigshafen.
Nov 2025: Adisseo; Technical service; Released the Microvit Nutrition Guide 2026, covering vitamin recommendations for 18 animal species.
Feb 2026: dsm-firmenich; Divestment; Agreed to sell its Animal Nutrition & Health business to CVC Capital Partners at an enterprise value of about EUR 2.2 billion, with completion expected at the end of 2026.
Mar 2026: Jiangxi Tianxin Pharmaceutical; Expansion; Brought its 350 tonnes cholesterol and 6 tonnes 25-hydroxy vitamin D3 project into use.
The PESTEL analysis below summarises the political, economic, social, technological, environmental and legal factors affecting the Global Feed Vitamins Market.
Profiles of 105 companies operating in the Feed Vitamins Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
3 interactive charts drawn from the Feed Vitamins Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Feed Vitamins Market By Livestock
Global Feed Vitamins Market By Vitamin Type
Global Feed Vitamins Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
